Prevention Genetics LogoExact Sciences is now Abbott
Test Code 10107
New York approved

Schwannomatosis Panel

3 genes

2 - 3 weeks (7 - 16 days STAT)

Need to add or remove a gene?

Who is this test for?
  • Individuals with relevant features who have a clinical or suspected diagnosis of schwannomatosis or NF2-related schwannomatosis.
  • Individuals with bilateral vestibular schwannomas with associated symptoms of tinnitus, hearing loss, and balance dysfunction.
  • Individuals with NF2-like presentation but absence of bilateral vestibular schwannomas
  • Children with retinal hamartoma, thickened optic nerves, cortical wedge cataracts, or third cranial nerve palsy with unknown cause.
  • Individuals with symptom onset between second and fourth decade of life
Method
NGS with CNV (PGselect Platform)
Specimen(s)

Blood, Buccal, Saliva, Tissue

Order Options

Test type
OTHER OPTIONS
for standard institutional pricing.

Questions? We can help.

Getting support has never been easier. Connect with our team for assistance with anything from test selection to interpreting results. Use the live chat button or visit our Contact us page.